Diagnostic Impact of Cerebrospinal Fluid Biomarker (Pre-)Analytical Variability in Alzheimer’s Disease
Intra- and inter-laboratory variability of cerebrospinal fluid (CSF) biomarker analyses remains an important issue. We investigated the clinical-diagnostic impact of CSF biomarker concentration shifts in mild cognitive impairment (MCI) and autopsy-confirmed Alzheimer’s disease (AD) dementia patients...
Main Authors: | , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
IOS Press
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927863/ |